Table 2. Median (and 95% confidence interval) of leukocyte cell population data (CPD) in healthy subjects and patients admitted to the intensive care unit (ICU) with or without sepsis.
| Parameters | Healthy subjects | All patients admitted to ICU | ||
|---|---|---|---|---|
| No sepsis | Sepsis | Septic shock | ||
| NE-SSC | 151.2γ (150.6–152.0) | 151.4§ (150.9–152.0) | 151.4£ (150.6–152.4) | 153.7 (152.8–154.9) |
| NE-WX | 312.5α (310.0–316.0) | 325.0& (323.0–328.0) | 329.0 (325.0–333.0) | 329.0 (321.0–340.0) |
| NE-SFL | 49.7α (49.4–50.3) | 55.7§ (55.1–56.3) | 56.8£ (55.7–57.6) | 61.7 (59.5–65.2) |
| NE-WY | 577.5α (572.0–586.0) | 653.0& (648.0–660.0) | 671.0£ (654.0–694.0) | 764.0 (729.0–812.0) |
| NE-FSC | 88.3 (87.9–89.0) | 87.9 (87.4–88.8) | 87.4 (87.0–88.4) | 88.4 (87.1–90.1) |
| NE-WZ | 770.5α (751.0–786.0) | 743.5& (726.0–759.0) | 772.0 (717.0–798.0) | 784.0 (751.0–815.0) |
| LY-X | 80.1α (79.6–80.4) | 83.0& (82.7–83.3) | 83.8 (83.3–84.2) | 84.7 (83.8–85.5) |
| LY-WX | 465.0β (461.0–471.0) | 474.0§ (467.0–480.0) | 481.0£ (470.0–490.0) | 510.0 (492.0–553.0) |
| LY-Y | 72.8α (72.3–73.5) | 77.3 (76.7–78.0) | 76.3 (75.2–77.7) | 81.6 (73.5–86.0) |
| LY-WY | 865.0α (853.0–873.0) | 902.0& (889.0–921.0) | 995.0 (963.0–1,022.0) | 991.0 (938.0–1,041.0) |
| LY-Z | 60.6 (59.8–60.9) | 59.3 (59.0–59.7) | 59.3 (58.8–60.3) | 59.4 (57.6–60.2) |
| LY-WZ | 610.0β (600.0–620.0) | 600.0& (591.0–607.0) | 630.0 (608.0–650.0) | 652.0 (610.0–742.0) |
| MO-X | 118.4α (117.7–118.7) | 123.5& (123.2–123.9) | 124.6£ (124.0–125.1) | 127.4 (126.6–127.8) |
| MO-WX | 261.0γ (258.0–264.0) | 258.0§ (254.0–261.0) | 264.0 (261.0–270.0) | 267.0 (260.0–280.0) |
| MO-Y | 115.0α (113.6–115.8) | 120.2§ (119.4–121.3) | 118.5£ (117.5–120.6) | 125.1 (122.0–129.3) |
| MO-WY | 682.5α (663.0–694.0) | 722.0& (710.0–731.0) | 762.0 (747.0–777.0) | 759.0 (734.0–778.0) |
| MO-Z | 65.7α (64.6–66.7) | 61.6 (61.1–62.0) | 60.8 (59.9–61.3) | 60.2 (59.1–62.1) |
| MO-WZ | 727.0β (712.0–748.0) | 717.5& (702.0–733.0) | 754.0 (727.0–777.0) | 785.0 (746.0–807.0) |
Statistically significant differences by Steel-Dwass-Critchlow-Fligner and by Kruskal-Wallis test with P<0.01. α, healthy subjects versus no sepsis, sepsis and septic shock; β, healthy subjects versus sepsis and septic shock; γ, healthy subjects versus septic shock; &, no sepsis versus sepsis and septic shock; §, no sepsis versus septic shock; £, sepsis versus septic shock. The full name of parameters are described in Table 1.